Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Admission to AIM

5th Apr 2013 07:00

RNS Number : 6327B
Healthcare Investment Opportunities
05 April 2013
 



 

5 April 2013

Healthcare Investment Opportunities Plc

(the "Company")

 

Admission to Trading on AIM

 

Healthcare Investment Opportunities Plc (AIM: HIO), an investment company focusing on the healthcare sector, announces its successful admission to trading on AIM today.

 

The Company has raised £4m gross, conditional on Admission, through the Placing of 40,000,000 new Ordinary Shares at a price of 10p per share with new investors.

 

Zeus Capital Limited is acting as Nominated Adviser and Broker in relation to the Admission and the market

capitalisation of the Company at Admission is expected to be £4.05m.

 

Admission will become effective and dealings in the Ordinary Shares on AIM will commence at 8.00am on 5 April 2013 under the trading symbol HIO.

 

The Board

The Board as a whole, and in particular David Evans (Chairman), has an extensive contact base and a proven record of creating value for investors through building businesses in the healthcare sector via a combination of organic and acquisitive growth. Examples include Axis Shield, BBI Holdings plc, DxS Ltd, EKF Diagnostics Holdings Plc, Epistem Holdings Plc, Scancell Holdings Plc and Sirigen Group Ltd. The rest of the Board is made up of Kevin Wilson (Non-Executive Director) and Malcolm Gillies (Non-Executive Director)

 

Use of proceeds

The funds raised will be used for working capital whilst the Board seek suitable investments and, where applicable, acquisitions in line with the Company's Investment Policy.

 

The Board, through its extensive network of contacts, has identified a number of potentially interesting investment opportunities, although formal discussions in respect of any of these opportunities have not yet commenced. The Board anticipates the first acquisition will be a reverse takeover, in accordance with the AIM Rules for Companies, will be subject to prior shareholder approval and the publication of an admission Document and is expected to be made within 6 months of Admission. In addition, the Board may also consider making other smaller acquisitions or investments although the Directors do not intend to create a portfolio of unconnected companies.

 

The Company's Admission document is available on the Company's website: www.healthcareinvestmentopps.co.uk

 

Enquiries:

 

Healthcare Investment Opportunities Plc

 

David Evans, Chairman

Tel: 07740 084 452

Zeus Capital (Nominated Adviser and Broker)

Ross Andrews / Nick Cowles (Corporate Finance)

Tel: 0161 831 1512

John Goold (Institutional Sales)

Tel: 020 7016 8925

 

Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Paul McManus 

Mob: 07980 541 893

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVRSDISIIV

Related Shares:

COS.L
FTSE 100 Latest
Value8,275.66
Change0.00